Smiths Medical - Smiths Group plc

Cookies

The cookie settings on this website are set to ‘allow all cookies’. Leaving your settings to ‘allow all cookies’ means you consent to a website remembering your preferences and generally enhancing the user experience. If you prefer a website to not remember your preferences, you can change your settings at any time by changing the privacy settings of your browser.

Find out more about cookies >


General enquiries

Smiths Medical
6000 Nathan Lane N.
Plymouth, Minnesota 55442
USA

T: +1 763 383 3000
F: +1 763 383 3679
info[DOT]asd[AT]smiths-medical[DOT]comwww.smiths-medical.com

Where we operate

We have operations in over 30 countries with manufacturing located in the US, UK, Mexico, Italy, Germany, Czech Republic, and China. We sell to approximately 120 markets and, while the US continues to be our largest single market with over 50% of sales, we continue to build our presence in developing markets.

View map


Doctor and child

Smiths Medical’s portfolio incorporates established brands and strong positions in select segments of the Infusion Systems, Vascular Access and Vital Care markets.

A combination of capital equipment and consumables, as well as growing software and service offerings, provides diversity within our portfolio, and continuous access to customers.

Key facts

2017 Revenue £951m

2017 Headline operating margin 22.0%


Principal operating regions

We sell our products in over 120 countries with operations in over 30, with manufacturing in North America, Europe and Asia.

Customers

Three-quarters of our revenue is derived from hospitals, while the remainder comes from surgery centres, clinics, home care providers and products sold to other OEMs.

Growth drivers

  • Ageing populations with increasing life expectancy and quality of life expectations
  • Growing incidence of chronic diseases
  • Increasing need for interoperable and connected systems
  • Growth of alternate site and home-based medical care
  • Rising healthcare spend in developing markets, offsetting budget constraints in developed markets

Financial highlights

Revenue performance £m
£951m

Revenue by sector

  • Infusion Systems 32%
  • Vascular Access 33%
  • Vital Care and Specialty Products 35%

Competitive strengths

  • Category leadership in our chosen markets
  • Highly recognised and respected brands
  • Category breadth and depth, including capital, consumable and software products
  • Reputation for quality and safety
  • Extensive global sales network

Useful links

 







back to top

Smiths Group divisions:

John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect, Flex-Tek

Smiths Group plc:
Registered office 4th Floor, 11-12 St James’s Square, London, SW1Y 4LB
Incorporated in England No. 137013
Copyright 2017 Smiths Group plc.
All rights Reserved | Legal Notice | Privacy Policy | Cookie Policy